Piper Sandler raises Travelers stock rating, target to $310

Published 24/01/2025, 10:44
Piper Sandler raises Travelers stock rating, target to $310

On Friday, Travelers Companies Inc. (NYSE:TRV), a $54.7 billion insurance giant trading at 11.5x earnings, received an upgrade in its stock rating from Piper Sandler analysts, shifting from Neutral to Overweight. Accompanying the upgrade was a significant increase in the price target, set now at $310, up from the previous target of $259. The upgrade follows a comprehensive review by the analysts in response to Travelers' robust fourth-quarter 2024 performance.

The company's earnings per share (EPS) estimates were revised upward as a result of the stronger-than-anticipated quarterly results. Piper Sandler's analysis led to the conclusion that Travelers stock is currently undervalued, a view supported by InvestingPro data showing the stock trading at an attractive P/E ratio relative to near-term earnings growth. The analysts noted Travelers' commercial lines showed margins that are likely more durable than previously considered, contributing to the positive outlook. The company maintains a "GREAT" overall financial health score.

Additionally, the speed at which profitability in personal lines is improving has surpassed expectations, complemented by impressive revenue growth of 12.2% in the last twelve months. This swift recovery is another factor behind the optimistic reassessment of the company's stock. Travelers' performance in the fourth quarter of 2024 has evidently played a key role in changing the perception of its future prospects.

The new price target of $310 reflects a confident stance on Travelers' value, suggesting that there is a significant upside potential for the stock. According to InvestingPro's Fair Value analysis, the stock appears undervalued, with multiple additional valuation metrics available through the platform's comprehensive Pro Research Report. This revised target points to the analysts' belief in continued strong performance and sustainable profitability within the company's operations.

Investors and market watchers will likely monitor Travelers' stock performance closely in the wake of this upgrade, as it signals a positive shift in market sentiment towards the insurance giant. The company's recent financial results, combined with its impressive 19-year streak of dividend increases and strong five-year returns as noted by InvestingPro, suggest a compelling investment case. The company's recent financial results and the analysts' subsequent actions could influence trading in the upcoming sessions.

In other recent news, Travelers Companies Inc. posted impressive Q4 results, exceeding analyst expectations with core earnings of $9.15 per share and revenue of $12.01 billion. The company's combined ratio improved to 83.2%, indicating higher underlying underwriting gains across all segments. The insurer also reported a 7% year-over-year growth in net written premiums, totaling $10.74 billion. Travelers achieved a record core income for the quarter at $2.1 billion, driven by robust growth in earned premiums and profitability. For the full year of 2024, the company posted a core income of $5.03 billion, marking a 64% increase from 2023, and grew its adjusted book value per share by 13% to $139.04. In terms of analyst actions, BMO Capital Markets raised Travelers' stock target to $297, while RBC Capital cut it to $268, and Evercore ISI increased it to $288. These are recent developments concerning Travelers Companies Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.